Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nazemi

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
The Journal of Clinical Investigation|June 15, 2022
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline gliomaSabine Mueller, Jared M Taitt, Javier E Villanueva-Meyer, et al.
The Journal of Clinical Investigation|August 21, 2020
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline gliomaSabine Mueller, Jared M Taitt, Javier E Villanueva-Meyer, et al.
Scientific Reports|June 4, 2016
IGF1R as a Key Target in High Risk, Metastatic MedulloblastomaMatthew N Svalina, Ken Kikuchi, Jinu Abraham, et al.
Neuro-Oncology|July 31, 2024
A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patientsMary Jane Lim-Fat, Jennifer A Cotter, Mehdi Touat, et al.
Neuro-Oncology|May 23, 2022
Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatricsKee Kiat Yeo, Sanda Alexandrescu, Jennifer A Cotter, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
The Journal of Clinical Investigation|June 15, 2022
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline gliomaSabine Mueller, Jared M Taitt, Javier E Villanueva-Meyer, et al.
The Journal of Clinical Investigation|August 21, 2020
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline gliomaSabine Mueller, Jared M Taitt, Javier E Villanueva-Meyer, et al.
Scientific Reports|June 4, 2016
IGF1R as a Key Target in High Risk, Metastatic MedulloblastomaMatthew N Svalina, Ken Kikuchi, Jinu Abraham, et al.
Neuro-Oncology|July 31, 2024
A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patientsMary Jane Lim-Fat, Jennifer A Cotter, Mehdi Touat, et al.
Neuro-Oncology|May 23, 2022
Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatricsKee Kiat Yeo, Sanda Alexandrescu, Jennifer A Cotter, et al.
Pageof 3